7 Best Small Cap Agriculture Stocks to Buy Now
The agriculture, food, and related industries contributed more than $1.5 trillion to U.S. gross domestic product (GDP) in 2023, according to data from the Bureau of Economic Analysis.
Genentech Inc (DNA)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (DNA) is currently associated with the following stock: Ginkgo Bioworks Holdings Inc. (DNA)
Sector: Healthcare
News See All
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2026 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2026 Earnings Call Transcript May 7, 2026Ginkgo Bioworks Holdings, Inc. misses on earnings expectations.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript
Daniel Waid Marshall: Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Coen, our CFO.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2025 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2025 Earnings Call Transcript November 6, 2025Ginkgo Bioworks Holdings, Inc. misses on earnings expectations.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2025 Earnings Call Transcript
Daniel Waid Marshall: Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership. I'm joined by Jason Kelly, our Co-Founder and CEO; and our new CFO, Steve Coen.
Billionaire Nicholas J. Pritzker's 8 Stocks with Huge Upside Potential
Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, a San Francisco-based venture capital firm established in 2013.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2025 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2025 Earnings Call Transcript May 6, 2025Ginkgo Bioworks Holdings, Inc. misses on earnings expectations.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript February 25, 2025Ginkgo Bioworks Holdings, Inc. misses on earnings expectations.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript
Megan LeDuc: Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
Hedge Fund Resource Center